Cancer Head and Neck Cancer

Table of Contents

Head and Neck Cancer Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Head and Neck Cancer Projects
--Amgen Inc
--Access Pharmaceuticals Inc
--Boehringer Ingelheim GmbH
--BioVex Inc
--CEL-SCI Corporation
--Bristol-Myers Squibb Company
--Eli Lilly & Co
--DAIICHI SANKYO COMPANY, LIMITED
--Genmab A/S
--Genentech Inc
--Imclone Systems Inc
--GlaxoSmithKline plc
--Introgen Therapeutics Inc
--INTRACEL Corp
--OSI Pharmaceuticals Inc
--Merck KGaA
--PharmaMar
--OXiGENE INC
--Viventia Biotech, Inc.
--Roche Holdings Ltd

--Top Companies in early stage Head and Neck Cancer Projects
--Advaxis Inc
--AstraZeneca Plc
--Callisto Pharmaceuticals Inc
--Daewoong Pharmaceutical Co. Ltd.
--EntreMed Inc
--Erimos Pharmaceuticals
--Expression Genetics, Inc.
--Hutchison MediPharma Ltd.
--multimmune GmbH
--Pharmacyclics Inc
--WILEX AG

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View